128
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms

, , , , , , & show all
Pages 182-190 | Received 27 Feb 2006, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yan Zhang, Dong Yang, Jin-Hong Zhu, Min-Bin Chen, Wen-Xiang Shen & Jing He. (2015) The Association Between NQO1 Pro187Ser Polymorphism and Urinary System Cancer Susceptibility: A Meta-Analysis of 22 Studies. Cancer Investigation 33:2, pages 39-40.
Read now
Emanuel Roth, Silvia Selinski, Christian Schikowsky, Thilo Seidel, Frank Volkert, Meinolf Blaszkewicz, Jan G. Hengstler & Klaus Golka. (2012) Bladder Cancer Survival in a Former Industrial Area in Saxony-Anhalt, Germany. Journal of Toxicology and Environmental Health, Part A 75:19-20, pages 1216-1225.
Read now

Articles from other publishers (11)

Nadezda Lipunova, Anke Wesselius, Kar K Cheng, Frederik J van Schooten, Jean-Baptiste Cazier, Richard T Bryan & Maurice P Zeegers. (2019) Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer. Biomarkers in Cancer 11, pages 1179299X1989725.
Crossref
Anne J. Grotenhuis, Aleksandra M. Dudek, Gerald W. Verhaegh, Katja K. Aben, J. Alfred Witjes, Lambertus A. Kiemeney & Sita H. Vermeulen. (2016) Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response. Bladder Cancer 2:1, pages 77-89.
Crossref
Sen Yang, Tao Jin, Hong-Xia Su, Jin-Hong Zhu, Da-Wen Wang, Shi-Jian Zhu, Sheng Li, Jing He & Ying-He Chen. (2015) The Association between NQO1 Pro187Ser Polymorphism and Bladder Cancer Susceptibility: A Meta-Analysis of 15 Studies. PLOS ONE 10:1, pages e0116500.
Crossref
Wu YouZuo LiChen JingXing Qian-WeiZhang Yu-PingLi Weng-GuangLi Hua-Lei. (2013) MTHFR C677T and A1298C Polymorphisms Were Associated with Bladder Cancer Risk and Disease Progression: A Meta-Analysis . DNA and Cell Biology 32:5, pages 260-267.
Crossref
Muzeyyen Izmirli. (2012) A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk. Molecular Biology Reports 40:1, pages 625-637.
Crossref
Zhan-Jing Guo & Chang-Long Feng. (2012) The NQO1 rs1800566 Polymorphism and Risk of Bladder Cancer: Evidence from 6,169 Subjects. Asian Pacific Journal of Cancer Prevention 13:12, pages 6343-6348.
Crossref
Brad A. Patrick, Amitava Das & Anil K. Jaiswal. (2012) NAD(P)H:quinone oxidoreductase 1 protects bladder epithelium against painful bladder syndrome in mice. Free Radical Biology and Medicine 53:10, pages 1886-1893.
Crossref
Diogo O. Escudero, Samir P. Shirodkar & Vinata B. Lokeshwar. 2011. Bladder Tumors:. Bladder Tumors: 23 41 .
Anne J Grotenhuis, Sita H Vermeulen & Lambertus A Kiemeney. (2010) Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response. Future Oncology 6:9, pages 1433-1460.
Crossref
Oshrat Hershkovitz Rokah, Ofer Shpilberg & Galit Granot. (2010) NAD(P)H Quinone Oxidoreductase Protects TAp63γ from Proteasomal Degradation and Regulates TAp63γ-Dependent Growth Arrest. PLoS ONE 5:6, pages e11401.
Crossref
Meilin Wang, Haixia Zhu, Guangbo Fu, Miaomiao Wang, Zhizhong Zhang, Qiang Lu, Shizhi Wang & Zhengdong Zhang. (2008) Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case–control study with meta-analysis. Clinical and Experimental Medicine 9:1, pages 9-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.